Strategic and innovative leadership
Judy D. Olian, PhD, became president of Quinnipiac University in July 2018.
Prior to joining Quinnipiac University, she served as dean of UCLA Anderson School of Management and John E. Anderson Chair in Management for 12.5 years. Under her leadership, UCLA Anderson hired a record number of faculty, expanded its prestigious Board of Visitors, and raised over $450 million for students and faculty support, innovative programming and capital improvements.
Prior to that, she was dean and professor of management at the Smeal College of Business Administration at Pennsylvania State University, and professor and senior associate dean at the Smith School of Business at the University of Maryland. Olian has also served as the chairman of the Association to Advance Collegiate Schools of Business (AACSB International), the premier business accrediting and management thought leadership organization in the world.
Widely published in journals on human resource management, top management team composition, and the business alignment of management systems, Olian wrote a weekly syndicated newspaper column and hosted a monthly television show on current topics in business. She is a sought‐after speaker and has consulted for major corporations. Olian serves on, or has been a member of, various advisory boards including the U.S. Studies Centre at the University of Sydney, Peking University Business School’s International Advisory Board, the Connecticut Workforce Council, AdvanceCT, the Business-Higher Education Forum, New Haven Promise, and Catalyst, a leading global think tank for women in business. She was also chair of the Loeb Awards for Business Journalism.
Born and raised in Australia, Olian received her BS in psychology from the Hebrew University, Jerusalem, and her MS and PhD in industrial relations from the University of Wisconsin, Madison. She currently serves on the board of directors of Ares Management, L.P., a publicly traded global alternative asset management firm; United Therapeutics, a publicly traded advanced biotech company; and Mattel, a publicly traded multinational toy manufacturing company.